Innovation at IGTP
The Can Ruti Campus is a multidisciplinary space, where several biomedical institutions that produce leading scientific research at both national and international level are located. The synergies they produce have created a unique ecosystem for the development of innovation projects.
On campus the different institutions promote translational medicine and professionals carry out research, foster innovative ideas and generate knowledge designed to meet unmet clinical needs. This atmosphere has led the Innovation Unit of the Germans Trias i Pujol Research Institute to create a technology transfer model based on:
- Promotion of a culture of innovation among researchers that encourages motivating work environments, favors the generation of ideas, creativity, collaborations between professionals and an entrepreneurial vocation.
- The provision of a program to support projects with transfer potential, which allows their valorization and facilitates their transfer and an economic return for the Institute.
- The promotion of an open innovation model that complements the skills and technologies developed at the IGTP and establishes collaborations with other centers, companies and service providers
- Consolidation of the leadership of the Institute in research and innovation and promotion of its international projection.
The annual indicators of the Institute show the growth of innovative proposals in recent years, proposals that are meeting some of the great challenges of R+D+i. With 10 spin-offs, more than 180 active patents and 25 licensing agreements, we are positioned as a center of reference and excellence in innovation in health.
The innovation model we use at the IGTP aims to catalyze and energize the projects that need to be commercialized. Through our program we support researchers in matters of validation of opportunities, funding, intellectual protection or transfer strategy.
Since April 2023, we are an EATRIS Expert Centre, enabling us to provide services related to innovation management and health technology assessment through this network.
INNOVATION POLICY AND STRATEGY
Innovation at IGTP in figures
-
25Incubated projects
-
8Technology offer portfolio
-
189Active patents
-
40Patent families
-
25License agreements
-
10Active spin-offs
Strategic alliances
Latest innovation news
HIPRA receives European Commission approval for the commercialisation of its COVID-19 vaccine adapted to the LP.8.1 variant
The demonstration of the vaccine's efficacy in its preclinical phase was carried out at the Comparative Medicine and Bioimage Centre of Catalonia, a trategic project of IGTP.
IGTP obtains the ISO 56001 certification in Innovation Management
IGTP strengthens its commitment to excellence in innovation management and consolidates its position as a leading research centre with the attainment of the international ISO 56001 certification. This milestone recognises the implementation of a consolidated innovation management system aligned with international standards.